Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2020-07-01
2023-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin C
NCT05843617
Bioavailability of Orally Ingested Vitamin C
NCT05183880
A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms
NCT06471023
Vitamin C's Antioxidant Effects and COPD Prognosis
NCT06664957
Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults
NCT06794255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liposomal vitamin C, 1 gram
Participants will consume 1 gram on study day
Liposomal vitamin C, 1 gram
after a blood draw 1 gram of vitamin c will be consumed followed by 3 additional blood draws
Liposomal vitamin C, 2 grams
Participants will consume 2 grams on study day
Liposomal vitamin C, 2 grams
after a blood draw 2 grams of vitamin c will be consumed followed by 3 additional blood draws
Liposomal vitamin C, 5 grams
Participants will consume 5 grams on study day
Liposomal vitamin C, 5 grams
after a blood draw 5 grams of vitamin c will be consumed followed by 3 additional blood draws
Placebo
Participants will consume placebo on study day
Placebo
after a blood draw placebo will be consumed followed by 3 additional blood draws
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liposomal vitamin C, 1 gram
after a blood draw 1 gram of vitamin c will be consumed followed by 3 additional blood draws
Liposomal vitamin C, 2 grams
after a blood draw 2 grams of vitamin c will be consumed followed by 3 additional blood draws
Liposomal vitamin C, 5 grams
after a blood draw 5 grams of vitamin c will be consumed followed by 3 additional blood draws
Placebo
after a blood draw placebo will be consumed followed by 3 additional blood draws
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.0 and 34.9 (inclusive);
* Willing to abstain from coffee, tea, and soft-drinks for at least one hour prior to a clinic visit;
* Willing to abstain from alcohol for at least 12 hours prior to a clinic visit;
* Willing to maintain a consistent habit of abstaining from exercising, tobacco use, and nutritional supplements on the morning of a study visit.
Exclusion Criteria
* Chemotherapy during past 12 months;
* Significant active uncontrolled illness (such as lymphoma, liver disease, kidney failure, heart failure).
* Previous major surgery to stomach or intestines \[(absorption of test product may be altered) minor surgery is not a problem, including appendix and gallbladder removal\];
* Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
* Food allergies related to ingredients in test product;
* Women who are pregnant, nursing, or trying to become pregnant.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Natural Immune Systems Inc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gitte Jensen, Ph.D.
Research Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gitte Jensen, PhD
Role: PRINCIPAL_INVESTIGATOR
NIS Labs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gitte Jensen
Klamath Falls, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS161-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.